 - All female subjects who are knowingly pregnant or breast feeding or do not use an adequate form of contraception the effect on the foetus and newborn have not yet been fully established so Rituximab should be avoided in these groups. Male patients receiving Rituximab should ensure adequate contraception for 12 months following treatment. 